Company / Financials
Charles River Laboratories Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$4.0B
FY2025 · -0.9% YoY
Net Income
-$144.3M
FY2025 · -750.1% YoY
Profit Margin
-3.6%
FY2025 · net income / revenue
ROE
-4.6%
FY2025 · return on equity
Total Assets
$7.1B
FY2025
Total Debt
-
FY2025
Equity
$3.2B
FY2025
ROA
-2.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$4.0B-0.9% YoYNet Income HistoryProfit after all expenses and taxes-$144.3M-750.1% YoYGross Profit HistoryRevenue minus cost of goods sold$211.8MCost of Revenue HistoryDirect costs of producing goods and services sold$289.7MOperating Income HistoryProfit from core business operations before interest and taxes$25.2M-88.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$743.1M-1.1% YoYInterest Expense HistoryCost of borrowing and debt obligations$73.9MIncome Tax HistoryTotal income tax expense$42.7M-37.1% YoYEPS (Basic) HistoryBasic earnings per share-$2.91-130.4% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$2.91-130.7% YoY